Travis Esquivel is an engineer, passionate soccer player and full-time dad. He enjoys writing about innovation and technology from time to time.

EURUSD Forex Analysis For Monday, July 2
Jul02

EURUSD Forex Analysis For Monday, July 2

EUR/USD Forex Analysis for July 2, 2018 First, we look into the last week’s trade and what happened on June 29, 2018, and it opens at 1.15674 and went high at 1.16898 and gone low 1.15575 and finally close at 1.16805. The calculated pivot point for the day is 1.1642 LEVELS FIRST LEVEL SECOND LEVEL THIRD LEVEL BUY LEVELS 1.1690 1.1720 1.1746 SELL LEVELS 1.1607 1.1551 1.1518 (Click on image to enlarge) EUR/USD pair takes a bearish trend due to negative results in Markit manufacturing PMI’s. Also, US Dollar holds stronger due to Germany political chaos. Some of the Notable events occurred and impact the pair considerably, they are EUR: Markit Manufacturing PMI (Spain) Act 53.4 Prev 53.4 EUR: Markit Manufacturing PMI (Italy) Act 53.5 Prev 52.7 EUR: Markit Manufacturing PMI (France) Act 52.5 Prev 53.1 EUR: Markit Manufacturing PMI (Germany) Act 55.9 Prev 55.9 EUR: Markit Manufacturing PMI Act 54.9 Prev 55.0 EUR: Markit Manufacturing PMI (Britain) Act 54.4 Prev 54.4 EUR: Unemployment Rate (Italy) Act 10.7% Prev 11.2%  EUR: Unemployment Rate Act 8.4% Prev 8.5% USD: ISM Manufacturing PMI at 10:00 HRS EST – Prev 58.7 USD: ISM Price Paid at 10:00 HRS EST – Prev 79.5

Read More
Adamis Enters Distribution Agreement With Novartis Unit Sandoz
Jul02

Adamis Enters Distribution Agreement With Novartis Unit Sandoz

Adamis Pharmaceuticals (ADMP) announced last night that it has entered into an exclusive distribution and commercialization agreement with Sandoz, a division of Novartis (NVS), to commercialize Symjepi or the emergency treatment of allergic reactions including anaphylaxis. Symjepi is epinephrine and competes against Mylan’s (MYL) EpiPen. Under the terms of the agreement, Sandoz will obtain the United States commercial rights to Symjepi in exchange for an upfront fee and potential performance-based milestones payments. Additionally, Adamis and Sandoz will equally share net profits, as defined in the agreement, generated from sales of Symjepi in the U.S. As part of the agreement, Sandoz will have commercial rights to the FDA-approved Symjepi Injection 0.3mg product, as well as the Symjepi Injection 0.15mg product if approved by the FDA. Under the agreement, Adamis will retain the right to commercialize both products in territories outside of the U.S. but has granted Sandoz the first right of negotiation for such territories. Adamis may also continue to develop the Symject injection platform for additional product candidates including the previously announced naloxone product candidate being developed to treat opioid overdose. Dr. Dennis J. Carlo, President, and CEO of Adamis stated, “We are very excited about our collaboration with Sandoz. They are among the top pharmaceutical companies in the world and we believe they have the commercial presence and proven track record to maximize the value of Symjepi. We believe the financial terms of this agreement have the potential to bring meaningful recurring revenue to Adamis and we look forward […]

Read More
E
                                                
                        The Morning Track – No Breaks
Jul02

E The Morning Track – No Breaks

Geopolitical fears remained front and center for the start of the third quarter trading. We are starting the quarter with risk off in equities, but bonds are not bid up enough to counter the pain and the USD is stronger. It’s Monday and the weekend news didn’t bring any relief for China and the trade tariffs looming. The EU warned of a $300bn hit to its auto sector over US car import tariffs. Nor did it bring much surprise, as Mexico elects AMLO as President– a left leaning populist with 53% of the vote. This brought the MXN 1.3% stronger to 19.6406 but it’s back over 20 again tracking USD gains elsewhere. The weekend didn’t offer up much respite for the embattled German Chancellor Merkel as she continues to face political turmoil over immigration with her coalition. Germany’s Interior Minister Seehofer offered to resign over the migration issue as he said the EU agreement did not go far enough. However, has delayed handing in the letter for one more day of talks. The weekend didn’t bring much clarity over Italy and the EU either, as Italy’s Salivini said next year’s European elections are an opportunity to create an “international alliance of populists” and overcome a “Europe of the elites.” The UK hopes for a Brexit deal continue to elude – with UK Robbin’s saying Brussels will not offer a bespoke trade deal and with the UK May Cabinet meeting later this week to discuss solutions. As for the oil market, Trump tweets on a side deal with Saudi […]

Read More
Major Asset Classes – Performance Review – Monday, July 2
Jul02

Major Asset Classes – Performance Review – Monday, July 2

Real estate investment trusts (REITs) in the US posted the strongest gain in June among the major asset classes. The gain marked a second straight month with securitized real estate topping the performance list. Although most market categories retreated last month, US REITs bucked the trend with a solid advance. The MSCI REIT Index increased 4.4% in June — the fourth consecutive monthly gain. Last month’s rally lifted the index to a new high for 2018 and close to the previous peak from last December. The asset class suffered a sharp correction in the first two months of this year, but since March US REITs have been rebounding. In three of the past four months, the index has been the top performer for the major asset classes. Stocks in emerging markets suffered the biggest loss in June. The MSCI Emerging Markets Index tumbled 4.2% last month, the fifth straight monthly setback and the longest run of losses in nearly three years. US equities managed to eke out a small gain in June. The Russell 3000 Index increased 0.7% last month – the third consecutive monthly advance. For the first half of 2018, Russell 3000 is up 3.2%. Meantime, US bonds continued to drift lower. The Bloomberg Aggregate Bond Index ticked down 0.1% last month. Year to date, the index is off 1.6%.   The negative bias for markets overall last month clipped the Global Market Index (GMI), an unmanaged benchmark that holds all the major asset classes in market-value weights. […]

Read More
Morning Call For Monday, July 2
Jul02

Morning Call For Monday, July 2

Overnight Markets And News Sep E-mini S&Ps (ESU18 -0.52%) this morning are down -0.53% and European stocks are down -0.57% as trade risks drag global equity markets lower. Sep COMEX copper (HGU18 -0.39%) is down -0.51% to a 9-1/4 month low, which undercut mining stocks and metals producers on concern trade tensions are beginning to slow global manufacturing activity. The Eurozone Jun Markit manufacturing PMI was revised downward to a 1-1/2 year low of 54.9 and the China Jun manufacturing PMI fell -0.4 to 51.5, weaker than expectations of -0.3 to 51.6. Asian stocks settled lower: Japan -2.21%, Hong Kong closed for holiday, China -2.51%, Taiwan -0.54%, Australia -0.27%, Singapore -0.91%, South Korea -2.25%, India -0.45%. China’s Shanghai Composite tumbled to a 2-1/3 year low and the Chinese yuan fell to a 9-month low of 6.632 per dollar as increased risks of a trade war with the U.S. and weaker-than-expected China Jun manufacturing data hammered Chinese stocks and the yuan. Japan’s Nikkei Stock Index fell to a 2-1/2 month low after Japan’s Q2 Tankan showed confidence among large manufacturers declined more than expected. The dollar index (DXY00 +0.22%) is up +0.33%. EUR/USD (^EURUSD -0.41%) is down -0.39% weaker on heightened political risks in Germany as Chancellor Merkel’s Christian Democratic party may lose its parliamentary majority due to a standoff on migration policies. The Interior Minister of the Bavarian Christian Social Union has threatened to resign from Merkel’s cabinet if no compromise is found on migration policy today. USD/JPY (^USDJPY +0.09%) is down -0.01%. Sep 10-year […]

Read More